Hualan Biological Engineering Inc. (002007.SZ)
002007.SZ Stock Price Chart
Explore Hualan Biological Engineering Inc. interactive price chart. Choose custom timeframes to analyze 002007.SZ price movements and trends.
002007.SZ Company Profile
Discover essential business fundamentals and corporate details for Hualan Biological Engineering Inc. (002007.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
25 Jun 2004
Employees
4.01K
Website
https://www.hualanbio.comCEO
Bei Fan
Description
Hualan Biological Engineering Inc., a biopharmaceutical company, researches, develops, produces, and commercializes plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics in the People's Republic of China. Its blood products comprise human albumin, human immunoglobulin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, human prothrombin complex, human coagulation factor VIII, lyophilized human thrombin for external use, freeze-dried human fibrin glue for surgery, and human fibrinogen. The company's vaccines consist of influenza virus split vaccine, recombinant hepatitis B vaccine, ACYW135 meningococcal polysaccharide vaccine, A H1N1 influenza virus split vaccine, and quadrivalent influenza virus split vaccine. The company has strategic alliance with the Chinese Academy of Sciences, and other scientific research institutes and scientific research companies. The company was founded in 1992 and is based in Xinxiang, the People's Republic of China.
002007.SZ Financial Timeline
Browse a chronological timeline of Hualan Biological Engineering Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Apr 2026
Upcoming earnings on 27 Mar 2026
Upcoming earnings on 28 Oct 2025
Upcoming earnings on 28 Aug 2025
Revenue estimate is ¥1.05B.
Dividend declared on 17 Jun 2025
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 17 Jun 2025.
Earnings released on 24 Apr 2025
EPS came in at ¥0.17 matching the estimated ¥0.17, while revenue for the quarter reached ¥867.61M, missing expectations by -17.74%.
Earnings released on 28 Mar 2025
EPS came in at ¥0.09 falling short of the estimated ¥0.22 by -59.09%, while revenue for the quarter reached ¥888.55M, beating expectations by +3.54%.
Earnings released on 29 Oct 2024
EPS came in at ¥0.26 falling short of the estimated ¥0.30 by -13.33%, while revenue for the quarter reached ¥1.84B, beating expectations by +20.25%.
Earnings released on 29 Aug 2024
EPS came in at ¥0.10 falling short of the estimated ¥0.14 by -28.57%, while revenue for the quarter reached ¥856.38M, missing expectations by -1.07%.
Dividend declared on 14 Jun 2024
A dividend of ¥0.30 per share was announced, adjusted to ¥0.30. The dividend was paid on 14 Jun 2024.
Earnings released on 25 Apr 2024
EPS came in at ¥0.14 surpassing the estimated ¥0.13 by +7.69%, while revenue for the quarter reached ¥778.94M, beating expectations by +2.57%.
Earnings released on 29 Mar 2024
EPS came in at ¥0.23 falling short of the estimated ¥0.26 by -11.54%, while revenue for the quarter reached ¥1.42B, missing expectations by -0.14%.
Earnings released on 29 Oct 2023
EPS came in at ¥0.30 falling short of the estimated ¥0.41 by -26.83%, while revenue for the quarter reached ¥2.33B, beating expectations by +63.95%.
Earnings released on 23 Aug 2023
EPS came in at ¥0.10 matching the estimated ¥0.10, while revenue for the quarter reached ¥704.58M, missing expectations by -69.03%.
Dividend declared on 14 Jun 2023
A dividend of ¥0.30 per share was announced, adjusted to ¥0.30. The dividend was paid on 14 Jun 2023.
Earnings released on 21 Apr 2023
EPS came in at ¥0.19 surpassing the estimated ¥0.17 by +11.76%, while revenue for the quarter reached ¥880.66M, missing expectations by -50.93%.
Earnings released on 29 Mar 2023
EPS came in at ¥0.10 falling short of the estimated ¥0.26 by -61.54%, while revenue for the quarter reached ¥914.64M.
Earnings released on 30 Oct 2022
EPS came in at ¥0.17 falling short of the estimated ¥0.28 by -39.29%, while revenue for the quarter reached ¥1.25B, beating expectations by +10.36%.
Earnings released on 22 Aug 2022
EPS came in at ¥0.19 surpassing the estimated ¥0.14 by +35.71%, while revenue for the quarter reached ¥1.71B, missing expectations by 0.00%.
Dividend declared on 16 Jun 2022
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 16 Jun 2022.
Earnings released on 28 Apr 2022
EPS came in at ¥0.13 falling short of the estimated ¥0.14 by -7.14%, while revenue for the quarter reached ¥640.65M, missing expectations by -5.71%.
Earnings released on 29 Mar 2022
EPS came in at ¥0.13 falling short of the estimated ¥0.39 by -66.67%, while revenue for the quarter reached ¥1.08B.
Earnings released on 29 Oct 2021
EPS came in at ¥0.33 matching the estimated ¥0.33, while revenue for the quarter reached ¥2.07B, meeting expectations.
Earnings released on 29 Aug 2021
EPS came in at ¥0.11 falling short of the estimated ¥0.23 by -52.17%, while revenue for the quarter reached ¥665.22M.
Dividend declared on 23 Jun 2021
A dividend of ¥0.30 per share was announced, adjusted to ¥0.30. The dividend was paid on 23 Jun 2021.
Earnings released on 29 Apr 2021
EPS came in at ¥0.14 surpassing the estimated ¥0.13 by +7.69%, while revenue for the quarter reached ¥623.38M.
Earnings released on 10 Mar 2021
EPS came in at ¥0.36 surpassing the estimated ¥0.27 by +33.33%, while revenue for the quarter reached ¥1.95B.
Earnings released on 31 Oct 2020
EPS came in at ¥0.25 falling short of the estimated ¥0.32 by -21.88%, while revenue for the quarter reached ¥1.69B.
Earnings released on 10 Aug 2020
EPS came in at ¥0.15 falling short of the estimated ¥0.19 by -21.05%, while revenue for the quarter reached ¥709.00M.
002007.SZ Stock Performance
Access detailed 002007.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.